Synergistic Effect of Digoxin and Cisplatin on Redox Imbalance in HeLa Cells
Authors:
- Duane Gischewski PereiraDPDuane Gischewski Pereira
- Israel José Pereira GarciaIGIsrael José Pereira Garcia
- Graziele Aparecida Silva MaiaGMGraziele Aparecida Silva Maia
- Jéssica Martins Moura de ValadaresJVJéssica Martins Moura de Valadares
- Ana Carolina Pacheco RamosARAna Carolina Pacheco Ramos
- Herica Lima SantosHSHerica Lima Santos
- Silvana Gisele Pegorin de CamposSCSilvana Gisele Pegorin de Campos
- José Augusto Fp VillarJVJosé Augusto Fp Villar
- Leandro A. BarbosaLBLeandro A. Barbosa
- Vanessa Faria CortesVCVanessa Faria Cortes
- 27 July 2026
- journal article
- research article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 44 (7) , e70273
Abstract
Our previous study demonstrated a potent synergistic antitumor effect between 1 nM digoxin and 1 μM cisplatin in cervical cancer cells, which was dependent on the modulation of the signaling pathway involving Na, K‐ATPase/Src. Because of the relationship between Na, K‐ATPase/Src and the modulation of oxidative stress, the aim of this study was to demonstrate the effect of combined treatment with digoxin and cisplatin on oxidative stress parameters in HeLa cells and the effect of treatment in non‐tumor cell lines. Analysis of oxidative stress parameters revealed a significant reduction in cellular antioxidant defense mechanisms, SOD activity, and content of reduced total thiol groups. Additionally, there was an increase in H 2 O 2 content within 24 h, confirming the elevated cellular oxidative stress during the combined treatment. Furthermore, lipid peroxidation and lipid droplet formation levels were evaluated, showing an increase in these parameters after 48 h of treatment, consistent with oxidative stress. Compared to the other tested cell lines, the combined treatment did not significantly alter cell viability compared to the control. Our data demonstrate that the synergistic antitumor effects of digoxin and cisplatin in HeLa cells are tightly associated with increased oxidative stress via activation of the Na, K‐ATPase/Src/ROS signaling pathway, may resulting in antiproliferative and pro‐apoptotic effects. These findings indicate that oxidative stress is a key component of the cellular response underlying the synergistic antitumor effects of digoxin and cisplatin.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ‐01915‐22)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (RED‐00110‐23)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Financiadora de Estudos e Projetos (1640‐22)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (409119/2023‐7)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (403646/2021‐9)
This publication has 71 references indexed in Scilit:
- Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosisArchives of Toxicology, 2022
- Antagonistic anticancer effect of paclitaxel and digoxin combinationJournal of Cellular Biochemistry, 2019
- Involvement of Src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viabilityJournal of Cellular Biochemistry, 2017
- Na, K-ATPase Cell Signaling Pathways and Cancer2015
- Therapeutic Ranges of Serum Digoxin Concentrations in Patients With Heart FailureThe American Journal of Cardiology, 2012
- Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancerCancer Chemotherapy and Pharmacology, 2008
- Preferential Energy- and Potential-Dependent Accumulation of Cisplatin–Gutathione Complexes in Human Cancer Cell Lines (GLC4 and K562): A Likely Role of MitochondriaJournal of Bioenergetics and Biomembranes, 2006
- Increase of lipid peroxidation by cisplatin in WI38 cells but not in SV40‐transformed WI38 cellsJournal of Biochemical and Molecular Toxicology, 2003
- Hydrogen peroxide production during experimental protein glycationFEBS Letters, 1990
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983